Type 1 Diabetes Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be 18 years old or older at the time you agree to join the study.
• You must have been diagnosed with Type 1 diabetes for more than 1 year, based on a doctor's assessment.
• You must have used an FDA-approved automated insulin delivery (AID) system at some point in the last 6 months (regular use is not required).
• You must have been using insulin for more than 6 months.
• You must be willing to switch to a specific type of insulin approved for use with the study's pump, as directed by the study team.
• You must have at least one supportive person (such as a family member or friend) who knows how to handle a severe low blood sugar emergency, can contact emergency services and the study team, and either lives with you or can reach you within about 30 minutes.
• You must not currently be pregnant or breastfeeding.
• If you are able to become pregnant, you must agree to use contraception during the study, and you must have a negative pregnancy test before starting; becoming pregnant or planning to become pregnant during the study would mean leaving the study.
• You must be willing to wear a Dexcom continuous glucose monitor (CGM) throughout each phase of the study.
• You must be willing to use the study's full system (CGM, insulin pump, and phone) during the relevant parts of the study.
• You must be willing not to start any new non-insulin diabetes medications during the trial.
• You must be willing to take part in all study activities, including attending in-person training sessions.
• You must have internet access at home and be willing to upload your data when needed.
• The study doctor must be confident that you can use all the study devices correctly and follow the study rules.
• You must be able to read and speak English proficiently.

Who may not be able to join:

• You are planning to start a new non-insulin diabetes medication (such as GLP-1 drugs or similar); however, if you have already been on a stable dose of one for at least a month, this may not apply (confirm with trial site).
• You are currently taking sulfonylurea medications (a type of diabetes pill).
• You have uncontrolled eye complications related to diabetes (such as active proliferative retinopathy) that are not being treated or are not responding to treatment.
• You are currently taking SGLT-2 or SGLT-1/2 inhibitor medications (a type of diabetes drug) due to the risk of a serious complication called euglycemic DKA.
• You have hemophilia or any other bleeding disorder.
• You have had a severe low blood sugar episode involving a seizure or loss of consciousness in the last 12 months.
• You have had a diabetic ketoacidosis (DKA) episode in the last 12 months.
• You are currently receiving peritoneal dialysis or hemodialysis (kidney dialysis treatments).
• You are currently being treated for adrenal insufficiency (a condition where your adrenal glands do not produce enough hormones).
• You are currently being treated for a seizure disorder.
• You have a thyroid condition (underactive or overactive thyroid) that is not well controlled with treatment.
• You are currently using oral or injectable steroid medications at the time of enrollment.
• You have a known ongoing skin sensitivity or reaction to adhesives that is not well managed.
• You have any other condition that the study doctor believes could put you or the study at risk (confirm with trial site).
• You are currently taking part in another interventional clinical trial.
• Your direct supervisor at your workplace or school is involved in running this trial.

Important: Always verify eligibility with the trial site directly before applying.